Latest

Everything we have published, newest first.

Policy · Regulation & Enforcement

FDA puts a major GLP-1 compounder on notice

In a September 18 warning letter, FDA said Empower Pharmacy appeared to compound semaglutide and tirzepatide products that were essentially copies of approved drugs in substantial quantities.

By longevitydocs™ editorsSep 27, 2026
FDA puts a major GLP-1 compounder on notice
Technology · Devices & At-Home Care

Lab-grade breath testing goes self-serve

PNOĒ's new mask runs an 8-minute breath test that claims to measure 23 metabolic markers, including a VO2-style fitness reading.

By longevitydocs™ editorsSep 27, 2026
Lab-grade breath testing goes self-serve
Diagnostics · Screening & Prevention

Alzheimer’s blood tests are for symptomatic patients, not screening

Four Alzheimer's blood tests now have FDA clearance, including PrecivityAD2 and Roche's Elecsys pTau217.

By longevitydocs™ editorsSep 27, 2026
Alzheimer’s blood tests are for symptomatic patients, not screening
Policy · Global Policy

$16.4 trillion: the economic case for prevention

A McKinsey Health Institute and Abu Dhabi Future Health whitepaper models an upper-bound scenario in which eliminating modifiable behavioral, metabolic, and environmental risks could add $16.4 trillion to annual global GDP in 2050.

By longevitydocs™ editorsSep 27, 2026
$16.4 trillion: the economic case for prevention
Technology · Wearables & Remote Monitoring

Your ring now carries your chart

Ultrahuman's new HealthEx add-on lets US ring users pull their medical records through TEFCA, the national health-data exchange.

By longevitydocs™ editorsSep 27, 2026
Your ring now carries your chart
Diagnostics · Biomarkers

Which longevity data is worth acting on?

For years, we said we didn’t have enough data for precision medicine. Now we have more than we can interpret.

By David Luu, MDSep 27, 2026
Which longevity data is worth acting on?
Research · New Studies

Caloric restriction improves a composite aging-biomarker index

Across 7 pooled RCTs (829 older adults), caloric restriction improved a six-marker index modeled on the TAME trial (CRP, IL-6, cystatin C, insulin, GDF-15 and TNF-R1).

By longevitydocs™ editorsSep 27, 2026
Caloric restriction improves a composite aging-biomarker index
Diagnostics · Screening & Prevention

Multi-cancer blood test performance in 35,900 adults (PATHFINDER 2)

PATHFINDER 2 evaluated the Galleri multicancer detection test in adults aged 50 and older.

By longevitydocs™ editorsSep 27, 2026
Multi-cancer blood test performance in 35,900 adults (PATHFINDER 2)
Research · New Studies

Menopause leaves a molecular signature linked to brain aging

Blood proteomics identified a 16-protein inflammatory, synaptic and Alzheimer’s-related signature (including CCL2, BACE1 and p-tau231).

By longevitydocs™ editorsSep 27, 2026
Menopause leaves a molecular signature linked to brain aging
Policy · Regulation & Enforcement

Deepfake doctors are selling pills

CBC reports that AI-generated ads using the faces and voices of prominent Canadian physicians are circulating on Facebook and TikTok, selling prostate treatments, joint pills and “$1 million satisfaction guarantees.” Dr.

By longevitydocs™ editorsSep 20, 2026
Deepfake doctors are selling pills
Policy · Licensure & Standards

Bill Targets Corporate Control of Doctors

The Stop Corporate Takeovers of Physicians Act, introduced Sept 16 by Senators Warren, Wyden and Merkley, would bar private equity, insurers and other non-physician-controlled businesses from owning or directing medical practices.

By longevitydocs™ editorsSep 20, 2026
Bill Targets Corporate Control of Doctors
Policy · Regulation & Enforcement

FDA opens the file on testosterone for menopause

On Sept 17, FDA’s Office of Women’s Health and Center for Drug Evaluation and Research (CDER) held a public workshop on testosterone use in menopausal women: benefits, dosing, lab interpretation and long-term safety, with the stated aim of informing research and drug development.

By longevitydocs™ editorsSep 20, 2026
FDA opens the file on testosterone for menopause
Clinical Practice · Guidelines & Standards

Ferritin below 30 is the new line

The 2026 American Society of Hematology guidelines in Blood Advances keep ferritin as the best first test. They move the adult low cutoff from below 15 to below 30.

By longevitydocs™ editorsSep 20, 2026
Ferritin below 30 is the new line
Clinical Practice · Practice Models

Where can I find a longevity doctor?

We hear this question more every week. From patients: “Who is the best in New York?” From colleagues: “Do you know someone who works on hormones and longevity?” From a friend: “I need a cardiologist who goes deeper than the guideline.”

By David Luu, MDSep 20, 2026
Where can I find a longevity doctor?
Research · New Studies

Regular exercise rewires immune cells at the chromatin level

We know exercise protects against metabolic disease and infection. This paper asks what it does to the blood.

By longevitydocs™ editorsSep 20, 2026
Regular exercise rewires immune cells at the chromatin level
Research · New Studies

REM sleep tracks lower risk across 83 diseases in 95,559 UK Biobank adults

Nearly 96,000 UK adults wore a wrist tracker for a week, and researchers followed their health records for about nine years, checking against more than a thousand diagnoses.

By longevitydocs™ editorsSep 20, 2026
REM sleep tracks lower risk across 83 diseases in 95,559 UK Biobank adults
Diagnostics · Biological Age

Aging Rate Indicators (ARI) measure pace, not accumulated age

A biological-age clock is an odometer: how far you have aged. An aging rate indicator, or ARI, would be a speedometer: how fast you are aging now.

By longevitydocs™ editorsSep 20, 2026
Aging Rate Indicators (ARI) measure pace, not accumulated age
Business · Deals & Funding

System raises $20M to own the peptide supply chain

System raised $20M to run the full chain: patient, US-licensed clinician, certified compounding pharmacy, front door.

By longevitydocs™ editorsSep 13, 2026
System raises $20M to own the peptide supply chain
Technology · Digital Health Infrastructure

Can your phone become a longevity clinic?

iOS 27 ships tomorrow. A Longevity tab, a Health Age built from VO2 max, resting heart rate, HRV, sleep and blood work, and a Quest panel of 50+ biomarkers ordered inside the app for $119.

By David Luu, MDSep 13, 2026
Can your phone become a longevity clinic?
Business · Care Delivery

Bryan Johnson’s Immortals Concierge: from $75k to $1M

Fully managed care from Johnson's medical team. Dedicated physician, coach, coordinator, full-body MRI, coronary CT, multi-cancer early detection, DEXA, 200+ biomarkers, epigenetic workups, Whoop and Oura, Blueprint supplements.

By longevitydocs™ editorsSep 13, 2026
Bryan Johnson’s Immortals Concierge: from $75k to $1M
Research · New Studies

Ask about the parents. It beats the polygenic score.

1,126 Swedish 70-year-olds, followed six years. Having two parents who lived past 85 tracked with less hypertension, higher MMSE, lower BMI, lower homocysteine, lower IL-6 and CRP, less smoking, and a slower rise in plasma pTau217.

By longevitydocs™ editorsSep 13, 2026
Ask about the parents. It beats the polygenic score.
Research · Clinical Trials

An AI-designed drug moved six aging clocks. In IPF patients. For 12 weeks.

Proteomic substudy of the Phase 2a IPF trial of rentosertib, Insilico’s TNIK inhibitor (n=42).

By longevitydocs™ editorsSep 13, 2026
An AI-designed drug moved six aging clocks. In IPF patients. For 12 weeks.
Clinical Practice · Practice Models

How to Design a Patient Journey for a Longevity Clinic

Three weeks ago this series started with why doctors are making the move. Then 26 physicians said what not to do. Last week, the systems. This week, the patient’s year, on one page.

By David Luu, MDSep 6, 2026
How to Design a Patient Journey for a Longevity Clinic
Technology · Wearables & Remote Monitoring

A hormone panel from behind the ear, n=12

Phira unveiled a behind-ear wearable that models estrogen, LH, and progesterone dynamics from skin temperature at 0.03°C resolution, not from blood or urine.

By longevitydocs™ editorsSep 6, 2026
A hormone panel from behind the ear, n=12
Business · Deals & Funding

Oura is going public with 3.6 million people's worth of data

Oura filed for a US listing with roughly $1.21B in revenue over nine months and more than 3.6M rings sold in the past year.

By longevitydocs™ editorsSep 6, 2026
Oura is going public with 3.6 million people's worth of data
Therapeutics · Metabolic Health

Tirzepatide earns its first outcomes label

FDA approved tirzepatide to reduce MACE in adults with type 2 diabetes at cardiovascular risk. The claim rests on SURPASS-CVOT against dulaglutide, an active comparator, with an 8% relative reduction.

By longevitydocs™ editorsSep 6, 2026
Tirzepatide earns its first outcomes label
Therapeutics · Metabolic Health

The Lp(a) drug moved the number, not the outcome

Novartis and Ionis reported topline Phase III results from Lp(a)HORIZON on September 4: 8,323 patients with elevated Lp(a) and established cardiovascular disease on guideline-directed therapy.

By longevitydocs™ editorsSep 6, 2026
The Lp(a) drug moved the number, not the outcome
Technology · AI in Medicine

ChatGPT is now reading your Epic chart

ChatGPT for Healthcare integrates with Epic. Authorized physicians can pull labs, medications, notes, and specialist documentation into ChatGPT, or use it embedded in Epic, with UCSF Health as the named pilot.

By longevitydocs™ editorsSep 6, 2026
ChatGPT is now reading your Epic chart
Research · Biology of Aging

Aging-related disease is now the largest burden a newborn will face

Using Global Burden of Disease data, the authors sort every disease into four life-stage clusters: infant, early adult, later adult, and ageing-related.

By longevitydocs™ editorsSep 6, 2026
Aging-related disease is now the largest burden a newborn will face
Therapeutics · Metabolic Health

Semaglutide, started late, extended life in mice

Female mice started daily semaglutide at 20 months, roughly a human mid-60s, and stayed on it for life. Median lifespan rose from 742 to 834 days, about 12%.

By longevitydocs™ editorsSep 6, 2026
Semaglutide, started late, extended life in mice
Clinical Practice · Guidelines & Standards

Is Your Clinic Longevity-Ready?

Longevity medicine should be more than a menu of tests and therapies. It should be physician-led, grounded in evidence, transparent about uncertainty, measured by outcomes, and supported by systems that protect patients and clinical judgment.

By David Luu, MDAug 30, 2026
Is Your Clinic Longevity-Ready?
Business · Clinics & Practices

Mistakes to Avoid When Building a Longevity Practice

Longevity medicine has a growing clinical literature and no operational one. Physicians opening practices have no published standards, no pricing benchmarks, no model comparisons, no software evaluations, and no account of what the first eighteen months actually cost.

By David Luu, MDAug 23, 2026
Mistakes to Avoid When Building a Longevity Practice
Clinical Practice · Field Reports

Why More Doctors Are Moving Into Longevity Medicine

Issue 102. I started watching Best Medicine on Netflix yesterday - don’t judge please. A heart surgeon leaves Boston for a village practice. He was used to treating the organ, fixing the patient, next.

By David Luu, MDAug 16, 2026
Why More Doctors Are Moving Into Longevity Medicine
Voices · Opinion

What People Get Wrong About Longevity Medicine

I have spent this year in a lot of different countries, different cities, different rooms. Same questions every time.

By David Luu, MDAug 9, 2026
What People Get Wrong About Longevity Medicine
Policy · Regulation & Enforcement

FDA advisory committee recommends six peptides for compounding

The question at hand was never whether these compounds should be FDA approved. It was whether a licensed 503A compounding pharmacy should be legally permitted to prepare them for an individual patient holding a valid prescription from a licensed clinician.

By David Luu, MDAug 2, 2026
FDA advisory committee recommends six peptides for compounding
Clinical Practice · Field Reports

Inside Shanghai and Seoul's top longevity clinics

I just spent two weeks in Shanghai and Seoul, meeting physicians and leaders and walking through their clinics and hospitals. Here is my honest summary, the opportunities and the challenges:

By David Luu, MDJul 19, 2026
Inside Shanghai and Seoul's top longevity clinics
Business · Care Delivery

The Longevity Tourism Boom

Longevity spa, longevity retreats, or longevity checkup. Longevity is everywhere. A hotel in the Swiss Alps is selling a “longevity suite” with cryotherapy and IV drips.

By David Luu, MDJun 28, 2026
The Longevity Tourism Boom
Voices · From the Editors

10 learnings from longevitydocs Cannes 2026

We started the way the Murphys started: by showing up and inviting everyone to the table. The White Party on the deck of the Majestic, mocktails on the water, then dinner at the Palm Beach. Everyone in white.

By David Luu, MDJun 14, 2026
10 learnings from longevitydocs Cannes 2026
Clinical Practice · Guidelines & Standards

What's a Longevity Doctor? 10 Traits

When I started medical school, I wanted to save lives. Surgery, transplants, the adrenaline of the ER. I trained to treat disease. But by the time I saw most patients, the damage was already done.

By David Luu, MDMay 31, 2026
What's a Longevity Doctor? 10 Traits
Business · Clinics & Practices

Acquire Patients Better: The Physician-Patient Fit Checklist

In startups, nothing happens until you find product-market fit. In longevity medicine, nothing happens until you find patient-physician fit (PPF).

By David Luu, MDMay 26, 2026
Acquire Patients Better: The Physician-Patient Fit Checklist
Business · Clinics & Practices

How to build a $1M longevity clinic

You are starting you longevity clinic or want to grow it. Like any business, you need a revenue target. I am using $1M because it is the number where investors start paying attention.

By David Luu, MDMay 17, 2026
How to build a $1M longevity clinic
Voices · From the Editors

Launching Jobs: refer, hire, partner

Every day we get demands for a new medical director, or a physician asking to refer a patient to another specialist. Hiring. Referrals. Partners. So we built Jobs.

By David Luu, MDMay 10, 2026
Launching Jobs: refer, hire, partner
Technology · Digital Health Infrastructure

The longevitydocs mobile app is live

News. Curated longevity medicine intelligence, daily. New research, business moves, regulatory shifts. Two minutes. You’re current.

By David Luu, MDMay 3, 2026
The longevitydocs mobile app is live
Voices · From the Editors

Once upon a time in Cannes

In 1959, my father landed in Cannes. He became a physician and participated in the creation of the first university diploma in acupuncture at the University of Montpellier.

By David Luu, MDApr 29, 2026
Once upon a time in Cannes
Voices · From the Editors

We are launching Events

Peer learning has always been a medical tradition. The conference was just the easiest format. There is no community without programming. A once-a-year gathering is not enough.

By David Luu, MDApr 19, 2026
We are launching Events
Voices · From the Editors

Rooms: the digital lounge for longevity doctors

There used to be a place where doctors talked to each other. Not in a chat thread. Not on a podcast. In a room.

By David Luu, MDApr 13, 2026
Rooms: the digital lounge for longevity doctors
Voices · Opinion

Should Doctors Build a Personal Brand?

This cover story started in our chat. One doctor shared the social media agency he uses. Full production. Other docs chimed in. Some impressed. Some skeptical. Most asking the same thing quietly: should I be doing this too?

By David Luu, MDApr 5, 2026
Should Doctors Build a Personal Brand?
Voices · From the Editors

Launching longevitydocs 2.0

In February, we asked you a simple question: what do you actually need? The answers were clear: a searchable forum, shared protocols, a resource library, direct messaging between members. Not a WhatsApp group. A real home.

By David Luu, MDApr 1, 2026
Launching longevitydocs 2.0
Business · Clinics & Practices

The Longevity Clinic Gold Rush

In 2020, longevity clinics were a niche experiment. In 2026, they are a global industry. Serotonin Centers crossed 100 franchise locations inside gyms. Next Health sold 50+ territories. Fountain Life raised $108M.

By David Luu, MDMar 22, 2026
The Longevity Clinic Gold Rush
Technology · Devices & At-Home Care

Ambient Longevity Already Exists.

What if the data needed to guide you toward a longer, healthier, happier life already existed… and nobody was using it?

By David Luu, MDMar 1, 2026
Ambient Longevity Already Exists.
Business · Care Delivery

The Longevity Care Battle: Physician vs Digital Platform

The battle for longevity medicine has begun. On one side: digital platforms armed with venture capital, AI tools, and frictionless patient acquisition.

By David Luu, MDFeb 15, 2026
The Longevity Care Battle: Physician vs Digital Platform
Technology · AI in Medicine

Welcome to Hippo: AI learning Assistant for longevity medicine

This morning I opened Hippo and asked it to create a Quiz session. Within minutes I'd tested my knowledge, found a gap I didn't know I had, and moved on with my newsletter. A quick, focused way to build longevity fluency.

By David Luu, MDFeb 8, 2026
Welcome to Hippo: AI learning Assistant for longevity medicine
Voices · Opinion

From Barber To Longevity Doctor

As physicians, we’ve spent decades mastering our craft. Now, technology is reshaping everything we thought we knew about how medicine works.

By David Luu, MDJan 25, 2026
From Barber To Longevity Doctor
Technology · Digital Health Infrastructure

The longevity clinic tech stack

Technology is moving faster than medicine’s infrastructure can support it. The FDA just exempted AI health tools from oversight. Tech companies are building ‘body-scan’ centers.

By David Luu, MDJan 18, 2026
The longevity clinic tech stack
Technology · AI in Medicine

The AI Doctor Is Born

The AI doctor didn’t arrive with a white coat or a press conference. It arrived quietly, and soon it will be everywhere.

By David Luu, MDJan 11, 2026
The AI Doctor Is Born
Voices · From the Editors

2026 - The Longevity Medicine Manifesto

Not wellness theater. Not optimization trends. Not biohacking content for social media. Real medicine: practiced by physicians, grounded in evidence, accountable to standards, impacting patient’s lives.

By David Luu, MDJan 4, 2026
2026 - The Longevity Medicine Manifesto
Voices · From the Editors

2025 Longevity Medicine Recap: What Accelerated, What Broke

When we started building in 2021, most people were still asking: “What is longevity medicine, exactly?” 2025 was the year longevity medicine escaped the clinic and entered society. Here’s what actually happened.

By David Luu, MDDec 21, 2025
2025 Longevity Medicine Recap: What Accelerated, What Broke
Clinical Practice · Guidelines & Standards

How to become a Longevity Doctor

This week, I was in rooms with physicians who believe deeply in the future of longevity medicine. What I heard wasn’t about hype or protocols, they are asking for standards to help them:

By David Luu, MDDec 15, 2025
How to become a Longevity Doctor
Clinical Practice · Field Reports

Longevity Tour: 50 Lessons from 5 Cities

1. Longevity medicine mirrors emergency medicine in the 1970s: early, undefined, debated but inevitable. 2. Three years ago these conversations were speculative. Today they are clinical, technical, and operational. 3.

By David Luu, MDDec 9, 2025
Longevity Tour: 50 Lessons from 5 Cities
Voices · From the Editors

Introducing longevitydocs.network

The longevity space is accelerating fast. Biomarkers, wearables, and AI are everywhere. But every company I speak with hits the same wall:

By David Luu, MDNov 30, 2025
Introducing longevitydocs.network
Diagnostics · Biomarkers

The Biomarker Gold Rush

Function Health raised $298M, dropped membership to $365/year, and launched Medical Intelligence Lab: an AI engine merging 160+ biomarkers, full-body imaging, wearables, and medical records into personalized protocols.

By David Luu, MDNov 23, 2025
The Biomarker Gold Rush
Clinical Practice · Field Reports

10 core challenges longevity doctors are facing right now

Last week, I met with 25 physicians passionate about evidence-based longevity medicine. What I heard wasn’t about the promising interventions, it was about the reality of building a new field from scratch.

By David Luu, MDNov 18, 2025
10 core challenges longevity doctors are facing right now
Research · Clinical Trials

Launching the First Longevity Clinical Trial Network

Longevity medicine is emerging fast. Yet as the field grows, so does the need for validation. Today, most interventions are supported by small studies, animal data, or anecdotal success.

By David Luu, MDNov 9, 2025
Launching the First Longevity Clinical Trial Network
Voices · Opinion

Doctor-Led Longevity: The New Standard of Care

Why physicians will define the next frontier of preventive medicine and make longevity accessible to everyone.

By David Luu, MDNov 2, 2025
Doctor-Led Longevity: The New Standard of Care
Voices · Opinion

The rise of TikTok medicine

A few years ago, we were worried about “Doctor Google.” Now we have “TikTok Docs” Medicine didn’t disappear with, newspapers, blogs or tweets, and it won’t disappear with reels.

By David Luu, MDOct 26, 2025
The rise of TikTok medicine
Technology · Digital Health Infrastructure

The longevity EMR of the future

We all feel it. The system just doesn’t work. So I decided to write about what should. I feel you, doctors. I’ve been there too. We’ve all tried them, and yet no platform truly fits how we practice longevity medicine.

By David Luu, MDOct 19, 2025
The longevity EMR of the future
Clinical Practice · Guidelines & Standards

What is longevity medicine? From origins to futurism

The desire to live longer and better is as old as humanity itself. From the Epic of Gilgamesh to the Taoist search for immortality and the Greek idea of bios kalos, meaning “the good life,” every civilization has sought to stretch time.

By David Luu, MDOct 12, 2025
What is longevity medicine? From origins to futurism
Therapeutics · Supplements & Peptides

Inside the longevitydocs Peptide Mastermind

If you walked into that room, you could feel it, the curiosity, the energy, the collective intelligence. From biology to regulation, the debate was intense, deeply respectful, and often humbling.

By David Luu, MDOct 7, 2025
Inside the longevitydocs Peptide Mastermind
Voices · From the Editors

Virtual Mastermind: live and recorded access is back

We heard you. After so many requests from physicians around the world, we’ve decided to bring back virtual live tickets + recordings for our upcoming Peptides Mastermind.

By David Luu, MDSep 21, 2025
Virtual Mastermind: live and recorded access is back
Business · Deals & Funding

Smart investments for physicians

This Friday, our Private Club dives into a question every physician-builder faces: how to invest wisely and strategically in longevity medicine.

By David Luu, MDSep 14, 2025
Smart investments for physicians
Voices · From the Editors

Certification Cohort 3 is open

We’re opening Cohort 3 of the Certified Longevity Physician™: for practicing MDs who want evidence, outcomes, and an elite peer circle.

By David Luu, MDSep 7, 2025
Certification Cohort 3 is open
Voices · From the Editors

longevitydocs Tables launch in the US

After traveling and meeting so many of you this year, one thing became clear: We need more space to connect, share, and learn from each other.

By David Luu, MDAug 31, 2025
longevitydocs Tables launch in the US
Diagnostics · Screening & Prevention

Longevity on a budget: the 50-cents-a-day promise

A VC-backed startup has launched a $199-per-year membership that promises to detect “over 1,000+ preventable conditions” through annual lab testing.

By David Luu, MDAug 24, 2025
Longevity on a budget: the 50-cents-a-day promise
Clinical Practice · Practice Models

longevitydocs Concierge

Finding a trusted longevity doctor is harder than it should be. Many people waste time searching online, bouncing between clinics, and wondering if they’re really getting the best care. It’s overwhelming, and often discouraging.

By David Luu, MDAug 17, 2025
longevitydocs Concierge
Therapeutics · Supplements & Peptides

Peptides: meet the doctors speaking at the Mastermind

That’s why we’re bringing together the physicians who study, research, prescribe, and teach about peptides, so you can learn directly from the best how peptides can transform your practice, improve patient outcomes, and keep you at the forefront of modern medicine.

By David Luu, MDAug 10, 2025
Peptides: meet the doctors speaking at the Mastermind
Voices · From the Editors

Readers in 100+ countries: why this matters

From physicians in Mumbai and Melbourne to entrepreneurs in Berlin and investors in São Paulo… we’re proving something powerful:

By David Luu, MDAug 3, 2025
Readers in 100+ countries: why this matters